title: Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome.
abstract: The purpose of this retrospective study was to examine the potential role of cerebral hemodynamic and metabolic factors in the outcome of patients with fulminant hepatic failure (FHF). Based on the literature, a hypothetical model was proposed in which physiologic changes progress sequentially in five phases, as defined by intracranial pressure (ICP) and cerebral blood flow (CBF) measurements. Seventy-six cerebral physiologic profiles were obtained in 26 patients (2 to 5 studies each) within 6 days of FHF diagnosis. ICP was continuously measured by an extradural fiber optic monitor. Global CBF estimates were obtained by xenon clearance techniques. Jugular venous and peripheral artery catheters permitted calculation of cerebral arteriovenous oxygen differences (AVDO2), from which cerebral metabolic rate for oxygen (CMRO2) was derived. A depressed CMRO2 was found in all patients. There was no evidence of cerebral ischemia as indicated by elevated AVDO2s. Instead, over 65% of the patients revealed cerebral hyperemia. Eight of the 26 patients underwent orthotopic liver transplantation-all recovered neurologically, including 6 with elevated ICPs. Of the 18 patients receiving medical treatment only, all 7 with increased ICP died in contrast to 9 survivors whose ICP remained normal (P < 0.004). Hyperemia, per se, was not related to outcome, although it occurred more frequently at the time of ICP elevations. Six patients were studied during brain death. All 6 revealed malignant intracranial hypertension, preceded by hyperemia. In conclusion, the above findings are consistent with the hypothetical model proposed. Prospective longitudinal studies are recommended to determine the precise evolution of the pathophysiologic changes.
authors.affiliation: Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. aggarwals@anes.upmc.edu
authors.forename: Shushma
authors.initials: S
authors.lastname: Aggarwal
authors.forename: Walter
authors.initials: W
authors.lastname: Obrist
authors.forename: Howard
authors.initials: H
authors.lastname: Yonas
authors.forename: David
authors.initials: D
authors.lastname: Kramer
authors.forename: Yoogoo
authors.initials: Y
authors.lastname: Kang
authors.forename: Victor
authors.initials: V
authors.lastname: Scott
authors.forename: Raymond
authors.initials: R
authors.lastname: Planinsic
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism*; D002560:Cerebrovascular Circulation / Q000502:physiology*; D018450:Disease Progression; D004453:Echoencephalography / Q000379:methods; D005260:Female; D006501:Hepatic Encephalopathy / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy; D006801:Humans; D007427:Intracranial Pressure / Q000502:physiology*; D017114:Liver Failure, Acute / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D011237:Predictive Value of Tests; D011336:Probability; D011379:Prognosis; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D017585:Ultrasonography, Doppler, Transcranial